UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 30, 2009
Cellu Tissue Holdings, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
| 333-118829 |
| 06-1346495 |
(State or other jurisdiction |
| (Commission |
| (IRS Employer |
of incorporation) |
| File Number) |
| Identification No.) |
|
|
|
|
|
1855 Lockeway Drive |
| 30004 | ||
(Address of principal executive offices) |
| (Zip Code) | ||
Registrant’s telephone number, including area code (678) 393-2651
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION
Cellu Tissue Holdings, Inc. issued a press release today announcing third quarter earnings for the quarter ended November 27, 2008. The press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.
The information in this Form 8-K, including the accompanying exhibit, is being furnished hereunder and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liability of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of the general incorporation language of such filing, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS
The following is being furnished as an exhibit to this Current Report on Form 8-K:
(d) Exhibits
99.1 Release, dated January 30, 2009, “Cellu Tissue Holdings, Inc. Announces Third Quarter 2009 Results,” furnished pursuant to Item 2.02
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Cellu Tissue Holdings, Inc. |
| (Registrant) |
|
|
Date: January 30, 2009 | By: /s/ David J. Morris |
| Mr. David J. Morris |
| Senior Vice President, Finance and |
2
EXHIBIT INDEX
99.1 Release, dated January 30, 2009 “Cellu Tissue Holdings, Inc. Announces Third Quarter 2009 Results”
3